Mandate

Vinge has advised RusForest in connection with a restructuring

April 12, 2013

Vinge has advised RusForest AB (publ), a Swedish forestry company with operations in Russia, (“RusForest”) as it has completed a series of transactions in order to reduce the company’s debt and inject new working capital. As a first step, RusForest reduced the nominal amount and amended the terms and conditions of a listed bond. Subsequently, the reduced nominal amount was swapped into equity in a debt-to-equity swap. RusForest subsequently raised new capital through a rights issue to existing shareholders and a directed issue to the new majority shareholder, the Russian investment company Nova Capital LLC.

Vinge’s team has primarily consisted of Jesper Schönbeck, David Andersson and Joakim Hagberg as well as Maria Schultzberg and Maria Doeser with respect to tax and Robert Wikholm with respect to insolvency issues.

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026